EP Patent

EP2009008A1 — Imatinib base, and imatinib mesylate and processes for preparation thereof

Assigned to Sicor Inc · Expires 2008-12-31 · 17y expired

What this patent protects

The present invention provides imatinib mesylate free of desmethyl imatinib, imatinib base free of desmethyl imatinib, processes for their preparation and pharmaceutical compositions of imatinib mesylate.

USPTO Abstract

The present invention provides imatinib mesylate free of desmethyl imatinib, imatinib base free of desmethyl imatinib, processes for their preparation and pharmaceutical compositions of imatinib mesylate.

Drugs covered by this patent

imatinib-mesylate (IMATINIB MESYLATE)

Patent Metadata

Patent number: EP2009008A1
Jurisdiction: EP
Classification: —
Expires: 2008-12-31
Drug substance claim: No
Drug product claim: No
Assignee: Sicor Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.